Home Helio Vision

Helio Vision

acquired
-
Developer of Treatment Drugs for Rare Fibroproliferative Diseases
Basic
Enterprise Profile

Basic Information

Helio Vision, Founded in 2016, Develops a Drug for Treating Rare Fibroproliferative Diseases That Cause Abnormal Scarring and Blindness After Retinal Surgery. Helio Vision's Solutions Have Achieved Breakthrough Progress in Preventing Blindness, Reducing Reoperation Costs, and Improving Patients' Quality of Life.
Helio Vision, Inc.
Massachusetts,United States of America
less than 15 people
January 01, 2016
--
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Gene Technology Biotechnology
Concept
Ophthalmology Ocular Diseases Therapeutic Products
Application Scenarios
Biologics Innovative Drugs